Skip to content

Investigator

Anne Davidson

FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · funded by NIAID, NIDDK

Companies
5

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$1.7M

Summed across those awards.

First award
May 1, 2019

Latest Apr 23, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    The role of autophagy in B cell tolerance

    $209k

    Apr 23, 2026NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11370768 (opens the source filing in a new tab)

  2. R01

    Dissecting the heterogeneity and function of myeloid cells in lupus nephritis

    $658k

    Feb 1, 2023NIDDKFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11247065 (opens the source filing in a new tab)

  3. T32

    T32 Training Grant in Translational Immunology

    $302k

    Sep 1, 2021NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11161607 (opens the source filing in a new tab)

  4. U19

    Collaborative Project-Predicting LN flare and activity by an analysis of blood and urine

    $251k

    May 1, 2019NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11192210 (opens the source filing in a new tab)

  5. U19

    Collaborative Project-Predicting LN flare and activity by an analysis of blood and urine

    $251k

    May 1, 2019NIAIDFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11520865 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources